Upregulated genes, such as FBXO7, appeared to be the promising peripheral biomarkers of SCM, which are differentially expressed across a series of cell subpopulations (B cell, CD14+ monocyte, and plasma cell) in the peripheral blood of patients with sepsis. This evidence concerns the gene CD14 and Sepsis.